
Ambr Institute is developing a medical software platform that integrates clinical, lifestyle, and omics data to empower doctors in adopting a more personalized and preventive approach to healthcare. Their platform provides comprehensive insights into individual biological processes, disease susceptibility, and treatment response, with a primary focus on precise risk stratification for age-associated and chronic diseases, rare cancers, and surgical outcomes. Ambr analyzes clinical information using explainable AI to calculate disease probabilities, identify risk factors, and draft preventive strategies, enabling doctors to obtain a fast overview of patients, manage expectations, develop prevention plans, and convince patients to engage in lifestyle actions or treatments by simulating their effects. They have ongoing collaborations with Bærum Hospital, Tampere University, Bergen University, and Haukeland Hospital for modules like 'Engage' (predicting post-operative complications and prehabilitation programs) and 'NEC-AID' (diagnosing Neuroendocrine carcinoma).

Ambr Institute is developing a medical software platform that integrates clinical, lifestyle, and omics data to empower doctors in adopting a more personalized and preventive approach to healthcare. Their platform provides comprehensive insights into individual biological processes, disease susceptibility, and treatment response, with a primary focus on precise risk stratification for age-associated and chronic diseases, rare cancers, and surgical outcomes. Ambr analyzes clinical information using explainable AI to calculate disease probabilities, identify risk factors, and draft preventive strategies, enabling doctors to obtain a fast overview of patients, manage expectations, develop prevention plans, and convince patients to engage in lifestyle actions or treatments by simulating their effects. They have ongoing collaborations with Bærum Hospital, Tampere University, Bergen University, and Haukeland Hospital for modules like 'Engage' (predicting post-operative complications and prehabilitation programs) and 'NEC-AID' (diagnosing Neuroendocrine carcinoma).